Molecular Biophysics and Integrated Bioimaging (MBIB) interim Division Director Junko Yano announced a change in leadership of the Cellular and Tissue Imaging (CTI) Department, effective January 1, 2023. Carolyn Larabell is stepping down as the Department Head, a position she has served in since July 2020. She will continue to be a member of the MBIB management team, serving as senior advisor to the Division Director. Suzanne Baker, a staff scientist whose research focuses on the methodology behind PET imaging and pharmacokinetic modeling applied to research in aging and dementia, will serve as the new CTI Department Head.
Announcements
FY22 Year-end Deadlines
As you plan for year-end activities related to proposals, subcontracts, bridge funding requests, travel expense reimbursements, and effort (LETS), please take note of the key dates that will help ensure that we meet the critical processing and close deadlines related to various financial elements.
2022 Performance Review Process
The 2021 Berkeley Lab performance review process (PMP) has officially kicked off. Read the announcement here.
2021 Performance Review Process
The 2021 Berkeley Lab performance review process (PMP) has officially kicked off. Read the announcement here.
FY22 Biosciences LDRD Information
The FY22 Laboratory Directed Research and Development (LDRD) process has now been initiated (see email from Director Witherell dated 12/14/2020). There will be Area-wide, Early Career, and Lab-wide Initiative tracks. Please see a description of these tracks in the call for proposals and the FY22 Bioscience Area priorities.
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 8
- Next Page »
Was this page useful?
Send
